Skip to content
10-Q

Quarterly Report

BIOAGE LABS, INC. BIOA

0001193125-26-213466

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 44.45M sh
Shares Diluted Q1 2026 · Mar 31, 2026 42.48M sh
Shares Diluted Q1 2026 · Mar 31, 2025 35.85M sh
Capex Q1 2026 · Mar 31, 2026 $26K
Capex Q1 2026 · Mar 31, 2025 $426K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$24.05M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$17.36M
Short Term Debt Q1 2026 · Mar 31, 2026 $1.16M
Short Term Debt Q1 2026 · Dec 31, 2025 $2.65M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $241.78M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $188.89M
Stockholders Equity Q1 2026 · Mar 31, 2026 $379.12M
Stockholders Equity Q1 2026 · Dec 31, 2025 $272.05M
Stockholders Equity Q1 2026 · Mar 31, 2025 $313.17M
Stockholders Equity Q1 2026 · Dec 31, 2024 $323.13M
Current Liabilities Q1 2026 · Mar 31, 2026 $15.83M
Current Liabilities Q1 2026 · Dec 31, 2025 $20.14M
Total Liabilities Q1 2026 · Mar 31, 2026 $18.53M
Total Liabilities Q1 2026 · Dec 31, 2025 $22.84M
Current Assets Q1 2026 · Mar 31, 2026 $391.86M
Current Assets Q1 2026 · Dec 31, 2025 $286.79M
Total Assets Q1 2026 · Mar 31, 2026 $397.65M
Total Assets Q1 2026 · Dec 31, 2025 $294.89M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.52
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.36
Eps Basic Q1 2026 · Mar 31, 2026 −$0.52
Eps Basic Q1 2026 · Mar 31, 2025 −$0.36
Sga Expense Q1 2026 · Mar 31, 2026 $7.74M
Sga Expense Q1 2026 · Mar 31, 2025 $6.79M
Rd Expense Q1 2026 · Mar 31, 2026 $20.41M
Rd Expense Q1 2026 · Mar 31, 2025 $11.11M
Net Income Q1 2026 · Mar 31, 2026 −$22.25M
Net Income Q1 2026 · Mar 31, 2025 −$12.93M
Operating Income Q1 2026 · Mar 31, 2026 −$25.38M
Operating Income Q1 2026 · Mar 31, 2025 −$16.45M
Revenue Q1 2026 · Mar 31, 2026 $2.77M
Revenue Q1 2026 · Mar 31, 2025 $1.45M